Evidence map›Paper›PMID 38706896›Full record

ArticleJournal of Cancer2024

Mendelian randomization combined with multi-omics explores the relationship between heart failure and cancer.

Tian Sun, Na Mei, Yanting Su, Shigang Shan, Wenbin Qian, Mengxi Li, Zhenwang Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tian SunHubei provincial key laboratory of diabetic cardiovascular diseases, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.
Na MeiHubei provincial key laboratory of diabetic cardiovascular diseases, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.
Yanting SuSchool of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.
Shigang ShanSchool of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.
Wenbin QianSchool of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.
Mengxi LiSchool of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.
Zhenwang ZhangHubei provincial key laboratory of diabetic cardiovascular diseases, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancerco-localisation analysisHFMRSMRtranscriptomic analyses

Identifiers

PMID38706896
PMCPMC11064263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.